IPHA Guidance on Direct HealthCare Professional Communication (DHPC)


The Irish Pharmaceutical Healthcare Association (IPHA) has produced a Guidance on Direct Healthcare Professional Communication (DHPC).


The distribution of DHPCs by several different companies for the same active ingredient or class effect can decrease the effectiveness of each individual communication. The IPHA Guidance sets out a simple, effective framework for companies to work together on a joint DHPC in the case where a DHPC has been mandated by the regulator for two or more companies.


In an endorsement of the Guide, the Health Products Regulatory Authority (HPRA) has updated its Guide to Marketing Authorisation Holders on DHPCs to reflect the IPHA Guidance, which became effective in April 2017.



IPHA is a member of -


For medicines and clinical trials information visit -

medicines.ieself-care.ieICTRP Portal